Steven Waggoner, MD

Gynecologic Oncology

Obstetrics and Gynecology

  • Division Chief, Gynecological Oncology, UH Case Medical Center
  • Associate Professor, Obstetrics and Gynecology, CWRU School of Medicine

Request an Appointment

Refer a Patient


  • Gender: Male
  • Online Personal Health Record Available

Board Certifications

American Board of Obstetrics and Gynecology - Gynecologic Oncology
American Board of Obstetrics and Gynecology - Obstetrics and Gynecology

Education & Training


1980, University of Puget Sound

Medical / Professional School(s)

1984, University of Washington


1985, Obstetrics and Gynecology - University of Chicago Medical Center


1988, Obstetrics and Gynecology - University of Chicago Medical Center


1991, Gynecologic Oncology - Georgetown University Hospital


Cervical Dysplasia, Gynecological Oncology, Obstetrics and Gynecology, Ovarian Cancer, Quality of Life

Office Locations

UH Landerbrook Health Center
5850 Landerbrook Dr
Ste 300
Mayfield Heights, OH 44124
Get Directions

UH Case Medical Center
Department of OB/GYN-Gynecological Oncology
11100 Euclid Ave
Cleveland, OH 44106
Get Directions

UH Mentor Health Center
9000 Mentor Ave
Ste 209
Mentor, OH 44060
Get Directions

UH Chagrin Highlands Health Center
3909 Orange Pl
Ste 1100
Orange Village, OH 44122
Get Directions

UH Ahuja Medical Center
1000 Auburn Rd
Kathy Risman Pavilion, Ste 300
Beachwood, OH 44122
Get Directions

UH Sharon Health Center
5133 Ridge Rd
Seidman Cancer Center, Ste 5
Wadsworth, OH 44281
Get Directions

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

For calendar year 2012, Steven Waggoner, MD did not disclose any Outside Relationships with Industry.